1. Jain R, Yadav D, Puranik N, et al. Sarcoidosis: Causes, Diagnosis, Clinical Features, and Treatments. J. Clin. Med. 2020.
2. Kamangar N. Sarcoidosis. Medscape. 2020.
3. Fontenot A, King TE. Pathology and pathogenensis of sarcoidosis. UpToDate. 2022.
6. Judson M A, Preston S, Hu K, et al Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis. Respiratory Medicine. 2019;152:14-19 DOI: https://doi.org/10.1016/j.rmed.2019.03.012
7. Loke WS, Herbert C, Thomas P. Sarcoidosis: Immunopathogenesis and Immunological Markers. International Journal of Chronic Diseases. 2013;92860:1-13 DOI:http://dx.doi.org/10.1155/2013/928601
12. Terwiel M, H.M Coline, Moorsel V. Clinical epidemiology of familial sarcoidosis: A systematic literature review. Respiratory Medicine. 2019;149:36-41 DOI:https://doi.org/10.1016/j.rmed.2018.11.022
13. Arkema EV, Cozier YC. Epidemiology of sarcoidosis: current findings and future directions.Ther Adv Chronic Dis. 2018;9(11):227–240 DOI: 10.1177/2040622318790197
14. Trien R, Cooper C.J, Paez D, et al. Interferon-alpha-induced Sarcoidosis in a Patient Being Treated for Hepatitis C. Am. J. Case Rep. 2014; 15: 235–238.
15. Brjalin V, Salupere R, Tefanov V, et al. Sarcoidosis and chronic hepatitis c: A case report. World J. Gastroenterol. 2012; 18: 5816–5820.
16. Grunewald J, Kaiser Y, Ostadkarampour M, et al. T-cell receptor—Hla-drb1 associations suggest specific antigens in pulmonary sarcoidosis. Eur. Respir. J. 2016; 47: 898–909.
42. Aubar F C, Lhote R, Amoura A, et al. Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J Intern Med 2019;0:1-7 DOI: https://doi.org/10.1111/joim.12991